Aveanna Healthcare Hits Day Low of $5.93 Amid Price Pressure

Aveanna Healthcare Holdings, Inc. has experienced a significant decline today, with the stock dropping by 10.33% as of March 19, 2026. The stock reached an intraday low of USD 5.93, reflecting a challenging trading session for the small-cap company in the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Aveanna's one-day performance stands in contrast to the S&P 500, which saw a modest decline of 0.27%. Over the past week, Aveanna has decreased by 9.82%, while its one-month performance shows a drop of 14.32%. Year-to-date, the stock has declined by 22.4%, compared to the S&P 500's decrease of 3.49%. However, on a yearly basis, Aveanna has managed to generate a return of 15.9%, slightly trailing the S&P 500's 16.41%. Despite today's downturn, Aveanna has reported strong financial metrics, including a net profit growth of 107.78% and a remarkable return on equity of 1,000.90%. The company has maintained high institutional holdings at 98.63%, indicating a robust interest from larger investors.